Eastwood Financial Statements From 2010 to 2025

Stocks . Canada . 
Stock . Eastwood Bio Medical Canada
EBM Stock  CAD 0.40  0.05  14.29%   
Eastwood Bio financial statements provide useful quarterly and yearly information to potential Eastwood Bio Medical Canada investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Eastwood Bio financial statements helps investors assess Eastwood Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Eastwood Bio's valuation are summarized below:
Gross Profit
454.4 K
Profit Margin
(0.65)
Market Capitalization
27.6 M
Enterprise Value Revenue
34.4545
Revenue
702.1 K
There are over one hundred nineteen available fundamental signals for Eastwood Bio Medical Canada, which can be analyzed over time and compared to other ratios. All traders should should verify Eastwood Bio's prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to climb to about 86.2 M in 2025. Enterprise Value is likely to climb to about 85.3 M in 2025

Eastwood Bio Total Revenue

896,282

Check Eastwood Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eastwood Bio's main balance sheet or income statement drivers, such as Interest Expense of 13.1 K, Selling General Administrative of 835.2 K or Selling And Marketing Expenses of 2.8 K, as well as many indicators such as Price To Sales Ratio of 157, Ptb Ratio of 82.46 or Days Sales Outstanding of 17.89. Eastwood financial statements analysis is a perfect complement when working with Eastwood Bio Valuation or Volatility modules.
  
This module can also supplement various Eastwood Bio Technical models . Check out the analysis of Eastwood Bio Correlation against competitors.

Eastwood Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets234.5 K246.9 K2 M
Slightly volatile
Other Current Liabilities545.4 K1 M1.1 M
Slightly volatile
Total Current Liabilities1.5 M1.4 M1.3 M
Slightly volatile
Current Deferred Revenue87.3 K83.1 K33.5 K
Slightly volatile
Accounts Payable51.6 K86.8 K47.9 K
Slightly volatile
Cash And Short Term Investments15.8 K16.6 K680.3 K
Slightly volatile
Net Receivables36.7 K38.6 K757.6 K
Slightly volatile
Common Stock Shares Outstanding71.8 M79.2 M64.4 M
Slightly volatile
Liabilities And Stockholders Equity418.2 K440.2 K2.1 M
Slightly volatile
Other Current Assets42.5 K44.8 K346 K
Slightly volatile
Total Liabilities1.5 M1.4 M1.3 M
Slightly volatile
Total Current Assets37.3 K39.3 K1.8 M
Slightly volatile
Common Stock4.7 M5.4 M3.9 M
Slightly volatile
Other Stockholder Equity7.6 K8.6 K9.3 K
Slightly volatile
Accumulated Other Comprehensive Income7.6 K8.6 K9.3 K
Slightly volatile
Inventory57.1 K93.9 K58.6 K
Slightly volatile
Property Plant And Equipment Net335.2 K207.6 K332.1 K
Pretty Stable
Capital Stock3.7 M4.2 M4.6 M
Slightly volatile
Short Term Debt18.9 K26.5 K13.1 K
Slightly volatile
Property Plant Equipment520.2 K512.9 K383 K
Slightly volatile
Other Assets31.7 K33.4 K249.5 K
Slightly volatile
Short and Long Term Debt Total38.5 K26.5 K27.3 K
Slightly volatile
Long Term Debt32.7 K40 K27.5 K
Slightly volatile
Property Plant And Equipment Gross916.5 K960.8 K842.9 K
Slightly volatile
Short and Long Term Debt62 K91.5 K39.1 K
Slightly volatile

Eastwood Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense13.1 K7.2 K10.6 K
Pretty Stable
Selling General Administrative835.2 K606.1 K723.1 K
Slightly volatile
Selling And Marketing Expenses2.8 K3 K42.6 K
Slightly volatile
Total Revenue896.3 K807.4 K790.1 K
Slightly volatile
Gross Profit444.1 K522.5 K414.2 K
Slightly volatile
Other Operating Expenses1.4 M1.6 M1.3 M
Slightly volatile
Cost Of Revenue452.2 K284.8 K375.9 K
Slightly volatile
Total Operating Expenses1 M1.3 M904.6 K
Slightly volatile
Reconciled Depreciation95.1 K123.7 K62.7 K
Slightly volatile

Eastwood Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock858.7 K966.1 K1.1 M
Slightly volatile
Begin Period Cash Flow15.8 K16.6 K613 K
Pretty Stable
Depreciation75 K123.7 K61.4 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio15779.68136
Very volatile
Days Sales Outstanding17.8931.3420.7362
Pretty Stable
Average Payables57.5 K72.9 K68.9 K
Pretty Stable
Capex To Depreciation0.03070.03230.2984
Slightly volatile
Inventory Turnover810.3 K418.1 K705.5 K
Very volatile
Days Of Inventory On Hand9.0E-49.0E-45.751
Slightly volatile
Payables Turnover3.433.6113.0178
Pretty Stable
Sales General And Administrative To Revenue0.750.880.7176
Very volatile
Average Inventory0.650.681.5 K
Pretty Stable
Capex To Revenue0.00250.00270.0115
Slightly volatile
Cash Per Share0.00750.00790.0118
Pretty Stable
Days Payables Outstanding69.6810586.6319
Pretty Stable
Current Ratio0.120.1314.8478
Slightly volatile
Receivables Turnover11.4512.05166
Slightly volatile
Graham Number0.06720.05230.0504
Pretty Stable
Capex Per Share2.0E-42.0E-42.0E-4
Slightly volatile
Average Receivables32.1 K43.8 K31.1 K
Slightly volatile
Revenue Per Share0.00760.01280.0113
Pretty Stable
Debt To Assets0.06070.110.0515
Slightly volatile
Operating Cycle20.1231.3422.793
Pretty Stable
Days Of Payables Outstanding69.6810586.6319
Pretty Stable
Ebt Per Ebit0.90.971.0752
Very volatile
Quick Ratio0.120.1314.8089
Slightly volatile
Cash Ratio0.01520.0167.9183
Slightly volatile
Days Of Inventory Outstanding9.0E-49.0E-45.751
Slightly volatile
Days Of Sales Outstanding17.8931.3420.7362
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.031.531.2452
Slightly volatile
Fixed Asset Turnover2.572.952.6222
Pretty Stable
Debt Ratio0.06070.110.0515
Slightly volatile
Price Sales Ratio15779.68136
Very volatile
Asset Turnover1.681.60.8477
Slightly volatile
Gross Profit Margin0.40.570.5293
Pretty Stable

Eastwood Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap86.2 M78.2 M88.7 M
Pretty Stable
Enterprise Value85.3 M77.8 M88 M
Pretty Stable

About Eastwood Bio Financial Statements

Eastwood Bio investors use historical fundamental indicators, such as Eastwood Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eastwood Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue83.1 K87.3 K
Total Revenue807.4 K896.3 K
Cost Of Revenue284.8 K452.2 K
Sales General And Administrative To Revenue 0.88  0.75 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(0.52)(0.55)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Eastwood Stock Analysis

When running Eastwood Bio's price analysis, check to measure Eastwood Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio is operating at the current time. Most of Eastwood Bio's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio's price. Additionally, you may evaluate how the addition of Eastwood Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY